Medicare Rx Plans Have 15% Margin Of Error In Bids, Consultant Says

Medicare prescription drug plans will be able to remain profitable in the early years of the drug benefit even if their costs exceed the assumptions underlying their bid by as much as 15%, according to an analysis performed by the Gorman Health Group